| HGHRX | SHSKX | HGHRX / SHSKX | |
| Total Expense Ratio | 1.63 | 0.75 | 217% |
| Annual Report Gross Expense Ratio | 1.63 | 0.75 | 217% |
| Fund Existence | 19 years | 9 years | - |
| Gain YTD | 11.710 | 7.793 | 150% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 837M | 6.6B | 13% |
| Annual Yield % from dividends | 0.00 | 0.39 | - |
| Returns for 1 year | -1.20 | -3.23 | 37% |
| Returns for 3 years | 10.49 | 7.28 | 144% |
| Returns for 5 years | -13.50 | -6.30 | 214% |
| Returns for 10 years | -0.40 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RNGFX | 80.08 | 0.22 | +0.28% |
| American Funds New Economy R5 | |||
| CSSYX | 24.53 | 0.03 | +0.12% |
| Columbia Select Small Cap Value Inst3 | |||
| AFDCX | 55.46 | 0.06 | +0.11% |
| American Century Large Cap Equity C | |||
| ESIFX | 13.01 | N/A | N/A |
| Eaton Vance Balanced R6 | |||
| CZMGX | 21.21 | -0.07 | -0.33% |
| Multi-Manager Growth Strategies Inst | |||